Piramal Pharma Sees Significant Open Interest Surge Amid Dynamic Trading Environment
Piramal Pharma Ltd has seen a notable rise in open interest, reaching 3,956 contracts, alongside a trading volume of 3,279 contracts. The stock outperformed its sector, hitting an intraday high of Rs 212.7, while delivery volume has decreased significantly compared to recent averages, indicating active market engagement.
Piramal Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 3,956 contracts, reflecting a rise of 551 contracts or 16.18% from the previous open interest of 3,405. The trading volume for the day reached 3,279 contracts, contributing to a total futures value of approximately Rs 6,541.33 lakhs and an options value of Rs 1,122,260.83 lakhs, culminating in a total value of Rs 6,873.19 lakhs.In terms of price performance, Piramal Pharma outperformed its sector by 1.91%, with the stock hitting an intraday high of Rs 212.7, marking a 3.09% increase. The stock is currently positioned above its 5-day and 20-day moving averages, although it remains below the 50-day, 100-day, and 200-day moving averages. Notably, there has been a decline in investor participation, with delivery volume dropping by 33.24% compared to the 5-day average.
Overall, the notable spurt in open interest alongside the stock's performance metrics highlights a dynamic trading environment for Piramal Pharma, reflecting ongoing market activity without indicating future trends.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
